Follitropin beta administered by a pen device in patients undergoing controlled ovarian hyperstimulation for IVF-ET.

被引：1
|
作者：
Lee, S [1 ]
Kim, C [1 ]
Lee, H [1 ]
Kim, S [1 ]
Chae, H [1 ]
Kang, B [1 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
来源：
FERTILITY AND STERILITY | 2005年 / 84卷
关键词：
D O I：
10.1016/j.fertnstert.2005.07.801
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S307 / S307
页数：1
相关论文
共 50 条
  • [1] Follicle-stimulating hormone receptor polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET.
    Choi, YM
    Yoon, JS
    Hwang, KR
    Kim, SH
    Lee, WD
    Moon, SY
    [J]. FERTILITY AND STERILITY, 2004, 82 : S206 - S207
  • [2] An open, randomized single-centre study to compare the efficacy and convenience of follitropin β administered by a pen device with follitropin α administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI
    Platteau, P
    Laurent, E
    Albano, C
    Osmanagaoglu, K
    Vernaeve, V
    Tournaye, H
    Camus, M
    Van Steirteghem, A
    Devroey, P
    [J]. HUMAN REPRODUCTION, 2003, 18 (06) : 1200 - 1204
  • [3] Estradiol production during controlled ovarian hyperstimulation correlates with the risk of pregnancy loss in pregnancies achieved after IVF-ET.
    Mitwally, MFM
    Abdel-Razeq, SS
    O'Gavaghan, H
    Crickard, K
    Suilivan, M
    [J]. FERTILITY AND STERILITY, 2004, 82 : S198 - S198
  • [4] Cytokines in older patients undergoing IVF:: the relationship to the response to controlled ovarian hyperstimulation
    Valbuena, D
    Albert, C
    Garrido, N
    Remohí, J
    Simón, C
    Pellicer, A
    [J]. HUMAN REPRODUCTION, 1998, 13 : 248 - 249
  • [5] C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for IVF cycle
    Orvieto, R
    Chen, R
    Ashkenazi, J
    Ben-Harush, A
    Bar, J
    Fisch, B
    [J]. HUMAN REPRODUCTION, 2004, 19 (02) : 357 - 359
  • [6] The dydrogesterone and FSH protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation in IVF/ICSI cycle
    Gurbuz, A. S.
    Gode, F.
    [J]. HUMAN REPRODUCTION, 2019, 34 : 107 - 107
  • [7] Serum GDF-8 levels change dynamically during controlled ovarian hyperstimulation in patients undergoing IVF/ICSI-ET
    Fang, Lanlan
    Yu, Yiping
    Zhang, Ruizhe
    He, Jingyan
    Sun, Ying-Pu
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [8] Serum GDF-8 levels change dynamically during controlled ovarian hyperstimulation in patients undergoing IVF/ICSI-ET
    Lanlan Fang
    Yiping Yu
    Ruizhe Zhang
    Jingyan He
    Ying-Pu Sun
    [J]. Scientific Reports, 6
  • [9] Follicle stimulating hormone as a predictor of ovarian response in women undergoing controlled ovarian hyperstimulation for IVF
    Ashrafi, M
    Madani, T
    Tehranian, AS
    Malekzadeh, F
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2005, 91 (01) : 53 - 57
  • [10] The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments
    Zhu, Xiuxian
    Ye, Hongjuan
    Fu, Yonglun
    [J]. MEDICINE, 2016, 95 (28)
12345